FDA Adverse Event Malfunction Summary report: N

ARCHITECT CYCLOSPORINE

MDR report key: 2955237 · Received February 11, 2013

Report

Report Number
1415939-2013-00038
Event Type
Malfunction
Date Received
February 11, 2013
Date of Event
January 23, 2013
Report Date
January 24, 2013
Manufacturer
ABBOTT LABORATORIES
Product Code
MKW
PMA / PMN Number
K080751
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). AN EVALUATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE.

Additional Manufacturer Narrative · 1

FURTHER INVESTIGATION OF THE CUSTOMER ISSUE INCLUDED A REVIEW OF THE COMPLAINT TEXT, IN-HOUSE TESTING, A SEARCH FOR SIMILAR COMPLAINTS, AND A REVIEW OF LABELING. IT WAS NOTED THAT SAMPLE HANDLING ISSUES WERE IDENTIFIED AT THE CUSTOMER SITE. AN ACCURACY TESTING PROTOCOL WAS EXECUTED USING LOT 18265M500; TESTING MET THE ACCEPTANCE CRITERIA AND DETERMINED THE REAGENT IS PERFORMING ACCEPTABLY. TRACKING AND TRENDING DID NOT IDENTIFY AN ADVERSE TREND. LABELING WAS REVIEWED AND FOUND TO BE ADEQUATE. BASED ON THE AVAILABLE INFORMATION NO PRODUCT DEFICIENCY AND NO MALFUNCTION OF THE ARCHITECT CYCLOSPORINE REAGENT LIST NUMBER 01L75, LOT NUMBER 18265M500, WAS IDENTIFIED.

Description of Event or Problem · 1

THE CUSTOMER OBSERVED DISCREPANT CYCLOSPORINE RESULTS WHILE USING THE ARCHITECT CYCLOSPORINE ASSAY. THE CUSTOMER PROVIDED THE FOLLOWING RESULTS (NG/ML): SID (B)(6): INITIAL 245.4, RETEST 113.5; COMPARED TO MASS SPEC RESULTS: 60, 70 NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
58389 ARCHITECT CYCLOSPORINE MKW ABBOTT LABORATORIES 18265M500

Patients

Seq Age Sex Outcome Treatment
1 ARCHITECT I1000SR ANALYZER| LN01L86-01, SN (B)(4)| ARCHITECT I1000SR ANALYZER| LN01L86-01, SN (B)(4)